Associated Papers
Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2 , and CYP2C9 variants.
Lönnberg KI et al.
Pharmacogenetics and Genomics, 2023
Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders.
Zampatti S et al.
Journal of Personalized Medicine, 2021
CYP2C9 and CYP2C19: Deep Mutational Scanning and Functional Characterization of Genomic Missense Variants.
Zhang L et al.
Clinical and Translational Science, 2020
[The pharmacogenetics of vitamin K antagonists: still a matter for discussion].
Moreau C et al.
La Revue De Medecine Interne, 2010
Comparison of performance of three commercial platforms for warfarin sensitivity genotyping.
Babic N et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2009
The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels.
Kerb R et al.
The Pharmacogenomics Journal, 2001
Prevalence of CYP2C9 and CYP2C19 variants and the impact on clopidogrel efficacy in patients having CYPC19*2 variant.
Mehta MP et al.
Indian Journal of Pharmacology, 0
Select a paper to view details